Abstract
Cardiovasculardiseasesinthecontextofdiabetesrepresentamaincauseofmorbidityandmortalitywithatwotothree
times higher risk of cardiovascular diseases in T2DM patients than in people without the condition (normoglycemia).
The current study aimed to assess some Cardiac markers (CK-MB, myoglobin and troponin) in Iraqi type two diabetic
patients with metabolic syndrome. The study was carried out on (60) patients with type-2 Diabetes mellitus who were
divided into 2 groups: (30) subjects having metabolic syndromes and (30) subjects without metabolic syndromes.
VenousbloodsamplesweretakenfrompatientswhovisitedtheMedicalCityHospital-Baghdadduringtheperiodfrom
November 2024 to January 2025.The results demonstrated highly signi cant differences between metabolic syndrome
andwithoutmetabolicsyndromegroupsinregardtoTGandHDL(p 0.001).Inaddition,therewasahighlysigni cant
difference (p 0.001) in CK-MB and Myoglobin levels between the two groups, and a signi cant variation was found
in Troponin I levels between these groups (p 0.003). We can conclude that a highly signi cant variation was found
between individuals with type-2 diabetes having metabolic syndrome and subjects having no metabolic syndromes in
regard to CK-MB, Troponin-1 and Myoglobin levels.
times higher risk of cardiovascular diseases in T2DM patients than in people without the condition (normoglycemia).
The current study aimed to assess some Cardiac markers (CK-MB, myoglobin and troponin) in Iraqi type two diabetic
patients with metabolic syndrome. The study was carried out on (60) patients with type-2 Diabetes mellitus who were
divided into 2 groups: (30) subjects having metabolic syndromes and (30) subjects without metabolic syndromes.
VenousbloodsamplesweretakenfrompatientswhovisitedtheMedicalCityHospital-Baghdadduringtheperiodfrom
November 2024 to January 2025.The results demonstrated highly signi cant differences between metabolic syndrome
andwithoutmetabolicsyndromegroupsinregardtoTGandHDL(p 0.001).Inaddition,therewasahighlysigni cant
difference (p 0.001) in CK-MB and Myoglobin levels between the two groups, and a signi cant variation was found
in Troponin I levels between these groups (p 0.003). We can conclude that a highly signi cant variation was found
between individuals with type-2 diabetes having metabolic syndrome and subjects having no metabolic syndromes in
regard to CK-MB, Troponin-1 and Myoglobin levels.
Keywords
CK-mb
metabolic syndrome
Myoglobin
troponin
Type-2 diabetes